rss
J Clin Pathol 60:1067-1068 doi:10.1136/jcp.2006.043356
  • Short report

Chromogenic in situ hybridisation (CISH) should be an accepted method in the routine diagnostic evaluation of HER2 status in breast cancer

Table 1

 HER2 1HC and FISH versus CISH data

IHC FISH
3+ 2+ 0/1+ +
CISH, chromogenic in situ hybridisation; FISH, fluorescence in situ hybridisation; IHC, immunohistochemistry;
CISH + 29 4 1 CISH + 5 0
7 12 108 0 19

This Article

Latest from JCP Education

Latest from JCP Education

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest Pathology jobs

Latest Pathology jobs